Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: A randomized, double-blind clinical trial

Clinical Infectious Diseases

Volumn 33, Issue 11, 2001, Pages 1807-1815

  DuPont, Herbert L ^a,b   Jiang, Zhi Dong ^a   Ericsson, Charles D ^a   Adachi, Javier A ^a   Mathewson, John J ^a   DuPont, Margaret W ^a   Palazzini, Ernesto ^d   Riopel, Lise M ^c   Ashley, David ^e   Sandoval, Francisco Martinez ^f  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Salix a Division of Valeant Pharmaceuticals North America LLC   (United States)

^d Alfa Wassermann SpA   (Italy)

^e Ministry of Health of Jamaica   (United States)

^f UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BICOZAMYCIN; CIPROFLOXACIN; PLACEBO; RIFAXIMIN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRAVELLER DIARRHEA; TROPIC CLIMATE; VOMITING;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DIARRHEA; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; KINETICS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RIFAMYCINS;

EID: 0035576899     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323814     Document Type: Article

References (28)

1. Travelers' diarrhea and toxigenic Escherichia coli
2. Emporiatric enteritis: Lessons learned from US students in Mexico
3. Prevention and treatment of travelers' diarrhea
4. Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative
5. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers
6. Rifaximin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria
7. Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy: A double-blind randomized trial
8. Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin
9. Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea
10. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico
11. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea
12. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica
13. Utility of oligodesoxy-ribonucleotide probes for detecting enterotoxigenic Escherichia coli
14. Enteroaggregative Escherichia coli
15. How to establish equivalence when data are censored: A randomized trial of treatments for B non-Hodgkin lymphoma
16. Comparison of orally absorbable and non-absorbable antibiotics in shigellosis: A double blind study with ampicillin and neomycin
17. Therapeutic efficacy of bicyclomycin for shigellosis experimentally induced in rhesus monkeys
18. Rifaximin: A non-absorbed antimicrobial in the therapy of travelers' diarrhea
19. Five versus three days of ofloxacin therapy for traveler's diarrhea: A placebo-controlled study
20. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years
21. An outbreak of multi-drug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104
22. Resistance in Campylobacter species: Increased resistance to fluoroquinolones and seasonal variation
23. An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea
24. Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children
25. Rifaximin treatment for acute recurrent diarrhea in children with genitourinary disorders
26. Rifaximin therapy of travelers' diarrhea: In vitro activity and fecal concentration after oral administration
27. Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin